Navigation Links
Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues

The Drug Information Association (DIA), in collaboration with the FDA, Oligonucleotide Therapeutics Society, Health Canada, and the American Association of Pharmaceutical Scientists, will host the 2nd Conference on Oligonucleotide-based Therapeutics (September 22 - 24; Falls Church, VA).

Horsham, PA (PRWEB) August 15, 2008 -- The [Drug Information Association (DIA)]], in collaboration with the FDA, Oligonucleotide Therapeutics Society, Health Canada, and the American Association of Pharmaceutical Scientists, will host the [2nd Conference on Oligonucleotide-based Therapeutics] (September 22 - 24; Falls Church, VA).

"Attendees can share product development and regulatory information in the areas of nonclinical, chemistry, manufacturing and control (CMC), and clinical development of Oligonucleotide-based therapeutic drugs with industry experts and international regulators," says Program Co-chair David H. Schubert, Vice President of Regulatory Affairs, Logical Therapeutics, Inc.

Sessions will discuss:

  • siRNAs
  • Non-Hybridization Dependent Oligonucleotides
  • Antisense Oligonucleotide Discovery and Development
  • Emerging Oligonucleotide Issues
  • Starting Materials and GMP Synthesis
  • Formulations and GMP
  • Establishing Proof of Structure
  • Stability of Drug Substance and Drug Product
  • Novel Chemistry
  • Clinical Applications of siRNAs
  • Clinical Opportunities for Manipulating MicroRNAs Pathways
  • Clinical applications of Antisense Oligonucleotides
  • Clinical Applications of Aptamers
  • Clinical Opportunities for Immunostimulatory Oligonucleotides
  • Delivery of Oligonucleotides

Keynote speakers will include Craig C. Mello, PhD, University of Mass Medical School and 2006 Nobel Laureate, and Alan B. Sachs, MD, PhD, Merck Research Laboratories.

The final day will feature a panel discussion with representatives from the EMEA, FDA, Health Canada and PMDA.

About the [Drug Information Association (DIA)]
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit or call 215-442-6100.

Joe Krasowski
Joe.Krasowski @

# # #

Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Shamir Optical Industry Ltd. to Host Conference Call Announcing Second Quarter 2008 Earnings Results
2. ChemBridge Research Laboratories, Inc. (CRL) has Established an Industry Record and Benchmark in Hit-to-Lead Libraries Turn-around Time
3. Anthem Blue Cross and Blue Shield in Colorado Introduces Industry Leading and Comprehensive Transparency Initiative to Colorado
4. Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications
5. REHACARE INTERNATIONAL 2008: Platform for Rehabilitation Industry
6. Southern Home Medicals Encore Medical Staffing Division Poised to Benefit from Major Growth in Nursing Industry
7. R&D and Regulatory Leaders in the Cosmetics/Personal Care Field Present Latest Industry Research at HBA Global Expo
8. Eularis Analyzes Most Effective Generics Defense Strategies With New Pharmaceutical Industry Report
9. Entertainment Industry Foundation Unites Major Studios and State of California for Historic Anti-Smoking Campaign
10. Advisory: Entertainment Industry Foundation, Gov. Schwarzenegger to Announce Major Hollywood Anti-Smoking Initiative
11. Lilly Supports Industry Code on Interactions with Healthcare Professionals
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... Md (PRWEB) , ... November 25, 2015 , ... ... Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for ... of this disease. The Periwinkle Pioneers, nominated by the public, will receive special ...
(Date:11/25/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... LLC has announced that it has undertaken significant expansion of its current state ... The investment is part of PharmaTech’s strategy to increase its manufacturing capacity as ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Calif. , Nov. 24, 2015 /PRNewswire/ ... leader in non-invasive genetic testing and the ... that it will present at the 27 ... York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, ... Company,s financial results, business activities and financial ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
(Date:11/24/2015)... Nov. 24, 2015  DILON Diagnostics and GE Healthcare ... agreement for DILON to distribute GE,s Discovery NM750b Molecular ... signing of this distribution agreement will provide Dilon,s experienced ... Imaging system and is considered an initial step in ... solutions for clinicians and their patients. ...
Breaking Medicine Technology: